Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (R01AI41444)
Received: 26 November 2020
Accepted: 15 December 2020
First Online: 20 January 2021
Change Date: 16 March 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/S13012-021-01093-4
Ethics approval and consent to participate
: This study protocol received institutional approval by the Research Ethics Committees from Moi University Institutional Research and Ethics Committee in Kenya (IREC/2019/304), Lagos State University Teaching Hospital Health Research and Ethics Committee (LREC/06/10/1304), and Duke University Health System Institutional Review Board (Pro00104256 and Pro00105072) and was registered on ExternalRef removed on 9 June 2020 with the public and scientific title “Malaria Diagnostic Testing and Conditional Subsidies to Target ACTs in the Retail Sector: the TESTsmART Trial Aim 2” (NCT04428307, NCT04428385). The trial sponsor is Walt Jones, RN, MPH, Clinical Project Manager NIH/NIAID/DMID/PIPB, 5601 Fisher’s Lane, Room 8A37, Rockville, MD 20892, ExternalRef removed. Current study protocol versions are Nigeria v2.0, approved 28 April 2020, and Kenya v1.1, approved 28 Feb 2020. Any updates to the protocol will be submitted for approval by the IRBs and reflected in the ExternalRef removed records. All public and scientific queries should be addressed to Wendy Prudhomme-O’Meara, ExternalRef removed.
: Not applicable.
: The authors declare that they have no competing or conflicting interests.